CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 73 filers reported holding CONCERT PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $171,719 | +145.3% | 29,404 | +182.4% | 0.00% | – |
| Q3 2022 | $70,000 | +25.0% | 10,412 | -37.4% | 0.00% | – |
| Q1 2022 | $56,000 | -49.5% | 16,627 | -37.0% | 0.00% | – |
| Q2 2021 | $111,000 | -31.9% | 26,404 | +58.6% | 0.00% | – |
| Q3 2020 | $163,000 | -63.9% | 16,647 | -4.4% | 0.00% | -100.0% |
| Q4 2017 | $451,000 | +46.4% | 17,421 | -14.3% | 0.00% | -50.0% |
| Q1 2015 | $308,000 | – | 20,330 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |